Syndax Pharmaceuticals, Inc. (SNDX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SNDX Syndax Pharmaceuticals, Inc.

交易中 04-22 15:47:42 EDT

12.75

+0.82

+6.87%

最高13.00	最低12.07	成交量109.62万
今开12.10	昨收11.93	日振幅7.84%
总市值10.97亿	流通市值9.81亿	总股本8,604万
成交额1,373万	换手率1.42%	流通股本7,696万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SNDX","market":"US","secType":"STK","nameCN":"Syndax Pharmaceuticals, Inc. ","latestPrice":12.75,"timestamp":1745351259760,"preClose":11.93,"halted":0,"volume":1096200,"delay":0,"floatShares":76958264,"shares":86044032,"eps":-3.722848,"marketStatus":"交易中","change":0.82,"latestTime":"04-22 15:47:42 EDT","open":12.1,"high":12.9999,"low":12.065,"amount":13733919.284400001,"amplitude":0.078365,"askPrice":12.77,"askSize":1409,"bidPrice":12.75,"bidSize":363,"shortable":3,"etf":0,"ttmEps":-3.722848,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1456981200000,"exchange":"NASDAQ","adjPreClose":11.93,"preHourTrading":{"tag":"盘前","latestPrice":12.44,"preClose":11.93,"latestTime":"09:00 EDT","volume":429,"amount":5062.900128,"timestamp":1745326833366},"postHourTrading":{"tag":"盘后","latestPrice":11.93,"preClose":11.93,"latestTime":"16:33 EDT","volume":37407,"amount":446267.51,"timestamp":1745267611126},"volumeRatio":0.632742,"optionData":{"bulkOrders":[{"symbol":"SNDX","call":false,"expireDate":1752811200000,"strike":"10.0","timestamp":1745348168937,"price":0.4,"volume":2000,"amount":80000,"type":"-"}]},"impliedVol":0.679,"impliedVolPercentile":0.7},"requestUrl":"/m/hq/s/SNDX","defaultTab":"news","newsList":[{"id":"2529809235","title":"Syndax Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.11%报12.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529809235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529809235?lang=zh_cn&edition=full","pubTime":"2025-04-22 22:09","pubTimestamp":1745330960,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日22时09分，Syndax Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.11%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.39%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法产品线。其候选产品包括 revumenib 和 axatilimab。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422220921a6c3e3a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422220921a6c3e3a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNDX"],"gpt_icon":0},{"id":"2526614610","title":"Syndax Pharmaceuticals, Inc.盘中异动 下午盘急速拉升5.04%报11.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526614610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526614610?lang=zh_cn&edition=full","pubTime":"2025-04-12 03:23","pubTimestamp":1744399419,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日03时23分，Syndax Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.04%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.13%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法产品线。其候选产品包括 revumenib 和 axatilimab。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412032339a4567bef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412032339a4567bef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNDX","BK4139"],"gpt_icon":0},{"id":"2518278453","title":"Syndax Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518278453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518278453?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:22","pubTimestamp":1741616534,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时22分，Syndax Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.07%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3400.89%、719.71%、414.19%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc，振幅分别为41.36%、40.24%、39.34%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222215a26a3846&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222215a26a3846&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNDX","BK4139"],"gpt_icon":0},{"id":"2518447940","title":"Syndax Pharmaceuticals, Inc.2024财年实现净利润-3.19亿美元，同比减少52.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518447940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518447940?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449670,"startTime":"0","endTime":"0","summary":"3月9日，Syndax Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-3.19亿美元，同比减少52.63%；其中营业收入为23.68百万美元，每股基本收益为-3.72美元。机构评级：截至2025年3月9日，当前有14家机构对Syndax Pharmaceuticals, Inc.目标价做出预测，其中目标均价为36.29美元，其中最低目标价为16.00美元，最高目标价为51.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000232a266b3dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000232a266b3dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNDX"],"gpt_icon":0},{"id":"2517660179","title":"花旗：维持Syndax Pharmaceuticals(SNDX.US)评级，由买入调整至买入评级, 目标价由45.00美元调整至42.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517660179","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517660179?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:02","pubTimestamp":1741107763,"startTime":"0","endTime":"0","summary":"花旗：维持Syndax Pharmaceuticals(SNDX.US)评级，由买入调整至买入评级, 目标价由45.00美元调整至42.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05010248524002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SNDX"],"gpt_icon":0},{"id":"2516772356","title":"Syndax Pharmaceuticals, Inc.盘中异动 急速下挫6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516772356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516772356?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:33","pubTimestamp":1741098834,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时33分，Syndax Pharmaceuticals, Inc.股票出现异动，股价快速下跌6.10%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aeon Biopharma, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1060.12%、1057.97%、418.64%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Ibio, Inc.，振幅分别为23.30%、12.57%、11.23%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223354abe7f059&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223354abe7f059&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNDX"],"gpt_icon":0},{"id":"2516637631","title":"Syndax Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.50%报16.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516637631?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:31","pubTimestamp":1741012300,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，Syndax Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.50%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.20%、24.44%、22.45%，振幅较大的相关个股有Entero Therapeutics Inc.、Cibus, Inc.、Galmed Pharmaceuticals Ltd.，振幅分别为15.16%、9.55%、9.35%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223140989a0f5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223140989a0f5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNDX"],"gpt_icon":0},{"id":"2516803756","title":"Syndax Pharmaceuticals(SNDX.US)：2024年Q4财报实现营收768万美元，前值为0美元，预期值为2223万美元；每股收益为-1.10美元，前值为-1.00美元，预期值为-1.08美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516803756","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516803756?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:13","pubTimestamp":1741003986,"startTime":"0","endTime":"0","summary":"Syndax Pharmaceuticals(SNDX.US)：2024年Q4财报实现营收768万美元，前值为0美元，预期值为2223万美元；每股收益为-1.10美元，前值为-1.00美元，预期值为-1.08美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03201348492140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SNDX"],"gpt_icon":0},{"id":"1115785598","title":"Syndax Pharmaceuticals 2024年第四季度GAAP每股收益$(1.10)低于预期$(1.01)，销售额$7.68M低于预期$85.91M","url":"https://stock-news.laohu8.com/highlight/detail?id=1115785598","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115785598?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:10","pubTimestamp":1741003813,"startTime":"0","endTime":"0","summary":"Syndax Pharmaceuticals  公布其季度每股亏损为$，低于分析师普遍预期的$，差距为8.91%。这是比去年同期每股亏损$减少了10%。以上内容来自Benzinga Earnings专栏，原文如下：Syndax Pharmaceuticals  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 8.91 percent. This is a 10 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $7.68 million which missed the analyst consensus estimate of $85.91 million by 91.06 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Syndax Pharmaceuticals 2024年第四季度GAAP每股收益$(1.10)低于预期$(1.01)，销售额$7.68M低于预期$85.91M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNDX"],"gpt_icon":0},{"id":"2514185187","title":"Syndax Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514185187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514185187?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:55","pubTimestamp":1740581709,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时55分，Syndax Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.05%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为4317.10%、151.99%、132.86%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Renovaro Inc.，振幅分别为127.12%、39.47%、29.31%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225509abddf2dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225509abddf2dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNDX","BK4139"],"gpt_icon":0},{"id":"2514869775","title":"Syndax Pharmaceuticals, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514869775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514869775?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:46","pubTimestamp":1740411998,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时46分，Syndax Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.01%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Addex Therapeutics Limited涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为228.64%、96.48%、28.21%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为151.09%、55.69%、53.34%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234639abdb1f9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234639abdb1f9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNDX"],"gpt_icon":0},{"id":"2513299714","title":"Syndax Pharmaceuticals, Inc.盘中异动 大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513299714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513299714?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:45","pubTimestamp":1740149114,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时45分，Syndax Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.00%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为80.32%、78.89%、35.14%，振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.，振幅分别为50.31%、46.92%、35.45%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224514abd7b29f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224514abd7b29f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNDX","BK4139"],"gpt_icon":0},{"id":"2509427249","title":"Syndax Pharmaceuticals, Inc.股价上涨10.17% 市值涨1.4亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509427249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509427249?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:31","pubTimestamp":1738852272,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时31分，Syndax Pharmaceuticals, Inc.股票出现异动，股价大幅上涨10.17%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Lipella Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Transcode Therapeutics, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3685.57%、328.87%、113.29%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Moleculin Biotech, Inc.、Invivyd, Inc.，振幅分别为19.38%、10.08%、9.48%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223112abc4d41e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223112abc4d41e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNDX","BK4139"],"gpt_icon":0},{"id":"2505781994","title":"Syndax Pharmaceuticals, Inc.盘中异动 急速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505781994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505781994?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:40","pubTimestamp":1737492016,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时40分，Syndax Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.01%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.79%。其相关个股中，Dogwood Therapeutics, Inc.、Camp4 Therapeutics Corporation、Channel Therapeutics Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为1692.55%、529.19%、191.55%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为103.72%、96.32%、69.14%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122044016a22aa221&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122044016a22aa221&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNDX"],"gpt_icon":0},{"id":"2503450808","title":"Syndax Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503450808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503450808?lang=zh_cn&edition=full","pubTime":"2025-01-15 00:01","pubTimestamp":1736870464,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日00时01分，Syndax Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.00%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Eterna Therapeutics Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为732.56%、446.87%、406.51%，振幅较大的相关个股有Eterna Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为167.51%、60.08%、59.20%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115000105a221ccb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115000105a221ccb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNDX"],"gpt_icon":0},{"id":"2502996128","title":"Syndax Pharmaceuticals, Inc.盘中异动 股价大跌5.07%报13.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502996128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502996128?lang=zh_cn&edition=full","pubTime":"2025-01-11 00:14","pubTimestamp":1736525663,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日00时14分，Syndax Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.07%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.57%。其相关个股中，Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1195.28%、744.69%、221.21%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为100.85%、88.52%、60.00%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111001423aba61b2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111001423aba61b2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNDX"],"gpt_icon":0},{"id":"2501727778","title":"Scotiabank：维持Syndax Pharmaceuticals(SNDX.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由18.00美元调整至16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501727778","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501727778?lang=zh_cn&edition=full","pubTime":"2025-01-08 21:52","pubTimestamp":1736344334,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Syndax Pharmaceuticals(SNDX.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由18.00美元调整至16.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/08215247277178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SNDX"],"gpt_icon":0},{"id":"2500976218","title":"Syndax Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500976218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500976218?lang=zh_cn&edition=full","pubTime":"2025-01-03 00:18","pubTimestamp":1735834698,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日00时18分，Syndax Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.07%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Mustang Bio, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Revelation Biosciences, Inc.、Mustang Bio, Inc.、知临集团较为活跃，换手率分别为1155.60%、216.80%、180.66%，振幅较大的相关个股有Mustang Bio, Inc.、Revelation Biosciences, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为146.61%、127.98%、125.71%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103001819ab9c0f64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103001819ab9c0f64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNDX"],"gpt_icon":0},{"id":"2500362613","title":"Syndax Pharmaceuticals, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500362613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500362613?lang=zh_cn&edition=full","pubTime":"2025-01-01 04:48","pubTimestamp":1735678091,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日04时48分，Syndax Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.19%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，知临集团、Onconetix, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃，换手率分别为3140.23%、2026.57%、361.93%，振幅较大的相关个股有知临集团、Onconetix, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为309.22%、265.45%、248.39%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501010448119856dc65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501010448119856dc65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNDX"],"gpt_icon":0},{"id":"2491669358","title":"Syndax Pharmaceuticals, Inc.盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491669358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491669358?lang=zh_cn&edition=full","pubTime":"2024-12-13 02:31","pubTimestamp":1734028286,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日02时31分，Syndax Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.06%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.03%。其相关个股中，Trevi Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3947.60%、1101.15%、90.12%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Palisade Bio, Inc.、Aptevo Therapeutics Inc.，振幅分别为129.16%、99.29%、95.90%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213023126a1e9bb04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213023126a1e9bb04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNDX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.syndax.com","stockEarnings":[{"period":"1week","weight":0.0614},{"period":"1month","weight":-0.1298},{"period":"3month","weight":-0.1273},{"period":"6month","weight":-0.3565},{"period":"1year","weight":-0.4264},{"period":"ytd","weight":-0.0976}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Syndax Pharmaceuticals, Inc.于2005年10月11日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，正在开发癌症疗法的创新管道。该公司正在开发revumenib，这是一种有效的、选择性的、menin-MLL结合相互作用的小分子抑制剂，用于治疗KMT2A重排或KMT2AR，也称为混合谱系白血病重排或MLLR，包括急性淋巴细胞白血病或ALL在内的急性白血病，以及急性髓细胞白血病或AML，以及necleophosmin 1，也称为NPM1，突变AML。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.047367},{"month":2,"riseRate":0.666667,"avgChangeRate":0.081651},{"month":3,"riseRate":0.555556,"avgChangeRate":0.051247},{"month":4,"riseRate":0.3,"avgChangeRate":-0.003441},{"month":5,"riseRate":0.444444,"avgChangeRate":0.006686},{"month":6,"riseRate":0.555556,"avgChangeRate":0.008456},{"month":7,"riseRate":0.555556,"avgChangeRate":0.011483},{"month":8,"riseRate":0.555556,"avgChangeRate":0.046113},{"month":9,"riseRate":0.555556,"avgChangeRate":-0.028471},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.074254},{"month":11,"riseRate":0.555556,"avgChangeRate":0.001387},{"month":12,"riseRate":0.444444,"avgChangeRate":0.03326}],"exchange":"NASDAQ","name":"Syndax Pharmaceuticals, Inc. ","nameEN":"Syndax Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Syndax Pharmaceuticals, Inc. (SNDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Syndax Pharmaceuticals, Inc. (SNDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Syndax Pharmaceuticals, Inc. ,SNDX,Syndax Pharmaceuticals, Inc. 股票,Syndax Pharmaceuticals, Inc. 股票老虎,Syndax Pharmaceuticals, Inc. 股票老虎国际,Syndax Pharmaceuticals, Inc. 行情,Syndax Pharmaceuticals, Inc. 股票行情,Syndax Pharmaceuticals, Inc. 股价,Syndax Pharmaceuticals, Inc. 股市,Syndax Pharmaceuticals, Inc. 股票价格,Syndax Pharmaceuticals, Inc. 股票交易,Syndax Pharmaceuticals, Inc. 股票购买,Syndax Pharmaceuticals, Inc. 股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Syndax Pharmaceuticals, Inc. (SNDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Syndax Pharmaceuticals, Inc. (SNDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}